Medical Bulletin 9/November/2022 Dr Rashi Prakash9 Nov 2022 4:00 PM ISTHere are the top medical news for the day:New one-stop guideline for cardiovascular health in CanadaMedications to follow to treat cardiovascular...
New drug, baxdrostat, offers hope to patients resistant to high blood pressure treatment: Phase 2 trial Dr Kartikeya Kohli9 Nov 2022 11:45 AM ISTThe highest dose of oral medication (Baxdrostat) in patients with treatment-resistant hypertension reduced blood pressure by 20 points.UK: A new class...
Clinical trial finds novel therapy markedly reduced lipoprotein(a) levels in people with cardiovascular disease Dr Rashi Prakash9 Nov 2022 9:15 AM ISTLipoprotein(a) is a special type of bad cholesterol that is believed to contribute to heart disease, but there are no approved pharmacological...
Novel drug pemafibrate neutral on reducing CV events among patients with diabetes with hypertriglyceridemia Dr. Kamal Kant Kohli8 Nov 2022 7:30 PM ISTIn preventive cardiology work up, measuring levels of triglycerides is a routine affair and lowering triglycerides with several classes of drugs is...
Extra parenteral amino acids not beneficial for extremely preterm infants: NEJM Medha Baranwal8 Nov 2022 8:30 AM ISTNew Zealand: Extra parenteral amino acids for five days after birth in infants with extremely low birth weight is not tied to survival free from...
Olpasiran markedly reduces lipoprotein(a) in atherosclerotic cardiovascular disease: NEJM Dr. Manav Aggarwal7 Nov 2022 8:00 PM ISTUSA: In patients with established atherosclerotic cardiovascular disease (ASCVD), olpasiran treatment remarkably reduced lipoprotein(a)...
Empagliflozin reduces risk of disease progression and death in high-risk CKD patients: NEJM Medha Baranwal7 Nov 2022 10:30 AM ISTUK: Empagliflozin therapy in patients with chronic kidney disease (CKD) lowers the risk of disease progression or death from cardiovascular causes in...
Psilocybin significantly reduces symptoms among patients with resistant depression: NEJM Dr. Kamal Kant Kohli6 Nov 2022 8:15 PM ISTAround 100 million people suffer with treatment-resistant depression globally which means they have not responded to at least two...
Medical Bulletin 4/November/2022 Isra Zaman4 Nov 2022 5:00 PM ISTHere are the top medical news for the day:Less gym time may yield same results: ResearchNew research from Edith Cowan University (ECU) has shown one...
Semaglutide significantly effective for weight loss in teenagers too: NEJM Study Medha Baranwal4 Nov 2022 11:30 AM ISTAustria: Semaglutide is an obesity drug that mimics a hormone called glucagon-like peptide-1 to target areas of the brain that decrease appetite and...
COMP360 psilocybin reduces depression symptoms: Phase 2b trial findings Isra Zaman4 Nov 2022 9:00 AM IST Approximately 100 million people in the world suffer with treatment-resistant depression, which means they have not responded to at least two...
Neonatal supplementation of omega-3 fatty acid improves intelligence scores in preterm infants: NEJM. Aditi3 Nov 2022 8:00 PM ISTAustralia: A recent study published in the New England Journal of Medicine has concluded that omega-3 fatty acid supplementation in first few...
